<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1-161-00
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2000
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ALBUTEIN 20% SOLN. FOR INJ
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ALBUMIN HUMAN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Intravenous infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        146.40
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GRIFOLS BIOLOGICALS" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GRIFOLS BIOLOGICALS
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GRIFOLS BIOLOGICALS LLC
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Albute in&reg; 20% is a solution for intravenous infusion containing proteins extracted from human plasma, which is the liquid part of the blood. Each bottle contains a solution of human albumin protein.</p><p>Albute in&reg; 20% belongs to a group of medicines known as blood substitutes and plasma protein fractions.</p><p>Albute in&reg; 20% is used to restore and maintain the circulatin g blood volume where volume deficiency has been demons trated, and use of a plasma substitute is appropriate. The choice of an albumin solution rather than an artificial plasma substitute will depend on the cl inica l situation of the individual patient, based on officia l recommendations.</p><p>Albute in&reg; 20% is used for,</p><p>&bull; Hypovolemia</p><p>&bull; Cardiopulmonary Bypass Procedures (Treatment Adjunct)</p><p>&bull; Acute Nephrosis (Treatment Adjunct)</p><p>&bull; Hypoa lbuminemia</p><p>&bull; Ovarian Hyperstimulation Syndrome</p><p>&bull; Neonatal Hyperbilirubinemia</p><p>&bull; Adult Respiratory Distress Syndrome (ARDS) (Treatment Adjunct)</p><p>&bull; Prevention of Central Volume Depletion after Paracentesis due to Cirrhotic Ascites (Treatment Adjunct)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>a. Do not use Albutein&reg; 20%</p><p>Albute in&reg; 20% is contraindicated in patients with severe anemia or cardiac failure in the presence of normal or increased intravascular volume .</p><p>The use of Albutei n&reg; 20% is contraindicated in patients with a history of al lergic reactions to albumin.</p><p>b. Take special care with Albutein&reg; 20%</p><p>If you think you are suffering from an allergic reaction with breathing difficulties, feeling weak or any other symptoms. the infus ion must be stopped immediately.</p><p>Tell your doctor if you are suffering from any of the&nbsp;following conditions:</p><p>A weak heart</p><p>Technical colors</p><p>High blood pressure</p><p>Oesophageal varices (enlarged veins in the oesophagus)</p><p>Pulmonary oedema (liquid accumulation in the lungs) Bleeding or blood clotting disorders</p><p>Severe anaem ia (absence of red blood cells) Problems with urine production</p><p>These conditions may rule out the use of Al butein&reg; 20% in your treatment, or cause the doctor to modify the dosage/ infusion rate to avoid complications.</p><p>Following reports that there exists a risk of potentially fata l hemolysis and acute renal failure from the inappropriate use of Sterile Water for Injection as a diluent for Albute in&reg; 20%, if dilution is required, acceptable diluents include 0.9% Sodium Chloride or 5% Dextrose in Water. Albute in&reg; 20% is made from pooled human plasma. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases,including a theoretica l risk for transmission of Creutzfeldt-Jakob disease (CJD).</p><p>Although no cases of transmission of viral diseases or CJD have ever been identified for albumin, the risk of infectious agents cannot be totally eliminated. The physician should weigh the risks and benefits of the use of this product and should discuss these with the patient.</p><p>Albute in&reg; 20% should be administered with caution to patients with low cardiac reserve. Rapid infusion may cause vascular overload with resultant pulmonary edema. Patients should be closely monitored for signs of increased venous pressure.</p><p>A rapid rise in blood pressure following infusion necessitates careful observation of injured or postoperative patients to detect and treat severed blood vessels that may not have bled at lower pressure</p><p>Patients with marked dehydration require administration of add itional fluids. Albu tein&reg; 20% may be administered with the usual dextrose and saline intravenous solutions. However , solutions containing protein hydrolysates or alcohol must not be infused through the same admin istration set in conjunction with Albutein&reg; 20% since these combina tions may cause proteins to precipitate.</p><p>20-25% human albumin solutions are relatively low in electrolytes compared to 4%-5% human albumin solut ions. Your electrolyte status should be monitored regularly and appropriate steps taken to restore or maintain the electrolyte balance when albumin is admin istered.</p><p>c. Using other medicines, herbal or dietary supplements</p><p>Albute in&reg; 20% must not be mixed with other med icinal products (except the recommended diluenl sl , whole blood and packed red cells.</p><p>Do not adm inister protein hydrolysates or alcohol via the same administration set used for Albute in&reg; 20%. It may cause proteins to precipitate.</p><p>Albute in&reg; 20% must not be diluted with sterile water for injection as this may cause hemolysis in recipients. The product can be diluted in an isotonic solution (e. g., 5% Dextrose in Water or 0.9% sodium chloride)</p><p>d. Taking other medicines, herbal or dietary supplements</p><p>No specific interactions of human albumin with other medicinal products are known.</p><p>e. Pregnancy and breast feeding</p><p>Animal reproduction studies have not been conduc ted with Albu tein &reg; 20%. It is also not known whether Albute in&reg; 20% can cause fetal harm when administe red to a pregnant woman or can affect reproductive capacity. Albute in&reg; 20% should be given to a pregnant woman only if clearly needed.</p><p>If you are pregnant or breast-feeding you must tell your doctor who will decide if Albutein&reg; 20% can be used.</p><p>f. Driving and using of machines</p><p>Albute in&reg; 20% has not been reported to affect the ability to drive or to operate machines.</p><p>g. Important information about some of the ingredients of Albutein&reg; 20%</p><p>Please inform your doctor if you are on a low sodium or potassium diet. This medicine contains sodium and potassi um, for this reason you should take into consideration that ,</p><p>Sodium may be harmful to you if you are on a low sodium diet.</p><p>Potassium is harmful to you if you are on a low potassium diet. It can also cause pain at the site of injection or inflammat ion of veins.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The concentration of the Albutein &reg; 20% preparation. dosage and the infusion-rate you receive will be adjusted to your individual requ irements. This will be calculated for you by your doctor.</p><p>Albute in&reg; 20% is administered intravenously. The tota l dosage will vary with the individual. In adults, an initia l infusion of 100 ml is suggested. Additional amounts may be administered as clinically indicated.</p><p>Inspect visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p><p>Directions for Use :</p><p>When an Administration Set is Used</p><p>Flip off plastic cap on top of the vial and expose rubber stopper. Cleanse exposed rubber with suitable germicida l solut ion, being sure to remove any excess. Observe aseptic technique and prepare sterile intravenous equipment as follows:</p><p>I. Close clamp on adm inistration set.</p><p>2. With bottle upright, squeeze drip chamber, thrust piercing pin straight through stopper center. Do not twist or angle.</p><p>3. Immediately invert bottle, release drip chamber to automatically establish proper fluid level drip chamber (half full).</p><p>4. Attach infusion set to administration set, open clamp and allow solution to expel air from tubing and needle, then close clamp.</p><p>5. Make venipuncture and adjust flow.</p><p>6. Discard all administration equipment after use. Discard any unused contents.</p><p>When an Administration Set is Not Used</p><p>Flip off plastic cap on top of the vial and expose rubber stopper. Cleanse exposed rubber stopper with suitable germicidal solution, being sure to remove any excess.</p><p>Observe aseptic technique and prepare sterile intravenous equipment as follows:</p><p>I. Using aseptic technique, attach filter needle to a sterile disposable plastic syringe.</p><p>2. Insert filter needle into Albutein&reg; 20%.</p><p>3. Aspirate Albutein &reg; 20% from the vial into the syringe.</p><p>4. Remove and discard the filter needle from the syringe.</p><p>5. Attach desired size needle to syringe.</p><p>6. Discard all administration equipment after use. Discard any unused contents.</p><p>If you use more Albutein&reg; 20% than you should</p><p>Hypervolemia may occur if the dosage and rate of infusion are too high. At the first clinical signs of cardiovascular overload (headache, dyspnea, jugula r vein congestion), or increased blood pressure, raised central venous pressure and pulmonary edema, the infusion should be stopped immediately and the patient&#39;s hemodynamic parameters carefully monitored.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Al butein&reg; 20% can cause side effects. although not everybody gets them.</p><p>The most serious adverse reactions are anaphylactic shock, heart failure and pulmonary edema.</p><p>The most common adverse reactions include fever and ch ills, rash, nausea, vomiting, tachycardia and hypotension. Should an adverse reaction occur, slow or stop the infusion for a short period of time which may result in the disappearance of the symptoms. If admin istrat ion has been stopped and the patient requires add itional Al butein &reg; 20%, material from a different lot should be used.</p><p>Albute in&reg; 20%, particularly if adm iniste red rapidly, may result in vascular overload with resultant pulmonary edema.</p><p>Because adverse reactions are reported voluntarily post&shy; approval from a population of uncertain size, it is not always possible to reliably estimate their frequency or to establish a causal relationship to product exposure. The following adverse reactions have been identified during post approval use of Albutein &reg; 20% in decreasing order of significance,</p><p>&bull; Anaphylactic shock</p><p>&bull; Heart failure</p><p>&bull; Pulmonary edema</p><p>&bull; Hypotension</p><p>&bull; Tachycardia</p><p>&bull; Vomiting</p><p>&bull; Urticaria</p><p>&bull; Rash</p><p>&bull; Headache</p><p>&bull; Chills</p><p>&bull; Fever</p><p>&bull; Flushing</p><p>&bull; Nausea</p><p>If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please&nbsp;tell your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not store above 30 &deg;C. Protect from freezing.</p><p>Do not begin administration more than 4 hours after the container has been entered. Discard unused portion.</p><p>Solutions of Albutein&reg; 20% should not be used if they appear turbid or if there is sediment in the bottle.</p><p>Do not use Albutein&reg; 20% after expiry date which is stated on the label and carton. Keep out of the reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance(s) is: human albumin U.S.P.</p><p>Every 1 ml of Alb utein&reg; 20% contains 200 mg of human albumin</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Al butein® 20% is a solution for infusion. The solution is clear and slightly viscous; it is almost colorless, yellow. amber or green.

Albutein® 20% is supplied in a vial containing 50 ml. Pack size 1 vial.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Grifols Biologicals LLC</p><p>5555 Valley Boulevard</p><p>Los Angeles, CA 90032, U.S.A.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 02/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            النشرة غير مترجمة للعربية حاليا لأن المستحضر للمستشفيات فقط، سوف يتم اضافة النشرة العربية بعد تقديمها واعتمادها من قبل الهيئة
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Albutein® 20% Solution for Injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2.1 Qualitative Composition
The active ingredient in Albutein® 20% is human albumin.
2.2 Quantitative Composition
• Active ingredient:
Albutein® 20% 50 mL contains 10 g of human albumin.
• Excipients:
Sodium Chloride (q.s sodium ion) 0.145 mmol
Sodium Caprylate 0.016 mmol
Sodium N- Acetyltryptophanate 0.016 mmol
Water for injection 1 mL
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Albutein® 20% solution is a clear, slightly viscous liquid; it is almost colorless, yellow, amber or green.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>4.1.1 Hypovolemia<br />For restoration and maintenance of circulating blood volume where hypovolemia is<br />demonstrated and colloid use is appropriate. When hypovolemia is long standing and<br />hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin<br />solutions should be used.<br />Acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia<br />can be present. Albutein&reg; 20% can be used in such cases.<br />Albutein&reg; 20% may be of value in the treatment of shock or hypotension in renal dialysis<br />patients.<br />4.1.2 Cardiopulmonary Bypass Procedures (Treatment Adjunct)<br />Preoperative dilution of blood using albumin and crystalloid can be used in<br />cardiopulmonary bypass procedures. Albumin also may be used in the priming fluid.<br />4.1.3 Acute Nephrosis (Treatment Adjunct)<br />Albutein&reg; 20% may be used to treat peripheral edema in patients with acute nephrosis<br />who are refractory to cyclophosphamide, corticosteroid therapy or diuretics.<br />4.1.4 Hypoalbuminemia<br />Abutein&reg; 20% may be indicated for subjects with hypoalbuminemia who are critically ill<br />and/or actively bleeding. When albumin deficit is the result of excessive protein loss, the<br />effect of Albutein&reg; 20% administration will be temporary unless the underlying disorder<br />is reversed. Septic patients and patients undergoing major surgery may lose more than<br />half of their circulating plasma volume. Treatment with Albutein&reg; 20% may be of value<br />in such cases, especially when plasma colloid oncotic pressure is abnormally low.<br />In the first 24 hours after thermal injury, large volumes of crystalloids are infused to<br />restore the depleted extracellular fluid volume. Beyond 24 hours, Albutein&reg; 20% can be<br />used to maintain plasma colloid osmotic pressure. Protein loss from the third space due to<br />infection (acute peritonitis, pancreatitis, mediastinitis or extensive cellulitis) may require<br />treatment with an infusion of albumin.</p><p>4.1.5 Ovarian Hyperstimulation Syndrome<br />Albutein&reg; 20% may be used as a plasma volume expander in fluid management relating to<br />severe forms of ovarian hyperstimulation syndrome.<br />4.1.6 Neonatal hyperbilirubinemia<br />Albutein&reg; 20% is indicated for the treatment of neonatal hyperbilirubinemia. It may be<br />used prior to or during an exchange procedure in an attempt to bind free bilirubin and<br />enhance its excretion.<br />4.1.7 Adult Respiratory Distress Syndrome (ARDS) (Treatment Adjunct)<br />Albutein&reg; 20% infusions may be indicated in conjunction with diuretics to correct fluid<br />overload and hypoproteinemia associated with ARDS.<br />4.1.8 Prevention of Central Volume Depletion after Paracentesis due to Cirrhotic<br />Ascites (Treatment Adjunct)<br />Albutein&reg; 20% may be used to maintain cardiovascular function following removal of<br />large volumes of ascitic fluid after paracentesis due to cirrhotic ascites.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For Intravenous Use Only<br />4.2.1 Dosage<br />Adjust the concentration, dosage and infusion rate of the albumin preparation to the<br />patient&rsquo;s individual requirements.<br />The dose required depends on the patient&rsquo;s body weight, severity of injury/illness and on<br />continuing fluid and protein losses. Use adequacy of circulating blood volume, not plasma<br />albumin levels, to determine the dose required.</p><p>&nbsp;</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:196px">Indication</td><td style="width:302px">Dose</td></tr><tr><td style="width:196px">Hypovolemia</td><td style="width:302px">Adults: Initial dose of 20 g.<br />If hemodynamic stability is not achieved within 15<br />to 30 minutes, an additional dose may be given.<br />Hemodilution may follow administration of<br />Albutein&reg; 20%. Anemia resulting from<br />hemorrhage should be corrected by administration<br />of compatible red blood cells or compatible whole<br />blood.<br />For acute liver failure: initial dose of 12 to 25 g.<br />An infusion rate of 1-2 mL per minute is usually<br />indicated. For renal dialysis, the initial dose should<br />not exceed 20 g and patients should be carefully<br />observed for signs of fluid overload.</td></tr><tr><td style="width:196px">Cardiopulmonary bypass<br />procedures</td><td style="width:302px">Adults: Initial dose of 25 g. Additional amounts<br />may be administered as clinically indicated.</td></tr><tr><td style="width:196px">Acute nephrosis</td><td style="width:302px">Adults: 25 g together with diuretic once a day for 7<br />&ndash; 10 days.</td></tr><tr><td style="width:196px">Hypoalbuminemia</td><td style="width:302px">Adults: 50 to 75 g<br />For pre- and post-operative hypoproteinemia: 50 to<br />75 g.<br />In burns, therapy usually starts with administration<br />of large volumes of crystalloid solution to maintain<br />plasma volume. After 24 hours: initial dose of 25 g<br />and dose adjustment to maintain plasma protein<br />concentration of 2.5 g per 100 mL or a serum<br />protein concentration of 5.2 g per 100 mL.<br />Third space protein loss due to infection: initial<br />dose of 50 to 100 g. An infusion rate of 1-2 mL per<br />minute is usually indicated in the absence of shock.<br />Treatment should always be guided by<br />hemodynamic response.</td></tr><tr><td style="width:196px">Ovarian hyperstimulation<br />syndrome</td><td style="width:302px">Adults: 50 g to 100 g over 4 hours and repeated at<br />4-12 hour intervals as necessary, when infusion of<br />normal saline fails to achieve or maintain<br />hemodynamic stability and urine output.</td></tr><tr><td style="width:196px">Neonatal hyperbilirubinemia</td><td style="width:302px">1 g per kilogram body weight prior to or during<br />exchange transfusion.</td></tr><tr><td style="width:196px">Adult respiratory distress<br />syndrome (ARDS)</td><td style="width:302px">Adults: 25 g over 30 minutes and repeated at 8<br />hours for 3 days, if necessary.</td></tr><tr><td style="width:196px">Prevention of central volume<br />depletion after paracentesis due to cirrhotic ascites</td><td style="width:302px">Adults: 8 g for every 1000 mL of ascitic fluid<br />removed.</td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Albutein® 20% is contraindicated in patients with severe anemia or cardiac failure in the
presence of normal or increased intravascular volume.
The use of Albutein® 20% is contraindicated in patients with a history of allergic
reactions to albumin.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>4.4.1 Hypersensitivity<br />Suspicion of allergic or anaphylactic reactions requires immediate discontinuation of the<br />infusion and implementation of appropriate medical treatment.<br />4.4.2 Hypervolemia/Hemodilution<br />Albutein&reg; 20% should be administered with caution to patients with low cardiac reserve.<br />Rapid infusion may cause vascular overload with resultant pulmonary edema. Patients<br />should be closely monitored for signs of increased venous pressure.<br />A rapid rise in blood pressure following infusion necessitates careful observation of<br />injured or postoperative patients to detect and treat severed blood vessels that may not<br />have bled at a lower pressure.<br />Hypervolemia may occur if the dosage and rate of infusion are not adjusted to the<br />patient&rsquo;s volume status. At the first clinical signs of cardiovascular overload (headache,<br />dyspnea, jugular venous distention, increased blood pressure), the infusion must be<br />slowed or stopped immediately.<br />Use albumin with caution in conditions where hypervolemia and its consequences or<br />hemodilution could represent a special risk to the patient. Examples of such conditions<br />are:<br />&bull; Decompensated heart failure<br />&bull; Hypertension<br />&bull; Esophageal varices<br />&bull; Pulmonary edema</p><p>&bull; Hemorrhagic diathesis<br />&bull; Severe anemia<br />&bull; Renal and post-renal anuria<br />4.4.3 Dehydration<br />Patients with marked dehydration require administration of additional fluids. Albutein&reg;<br />20% may be administered with the usual dextrose and saline intravenous solutions.<br />However, solutions containing protein hydrolysates or alcohol must not be infused<br />through the same administration set in conjunction with Albutein&reg; 20% since these<br />combinations may cause the proteins to precipitate.<br />The colloid-osmotic effect of human albumin 20% is approximately four times that of<br />blood plasma. Therefore, when concentrated albumin is administered, care must be taken<br />to assure adequate hydration of the patient. Patients should be monitored carefully to<br />guard against circulatory overload and hyperhydration. Patients with marked dehydration<br />required administration of additional fluids.<br />4.4.4 Electrolyte Imbalance<br />20% - 25% human albumin solutions are relatively low in electrolytes compared to 4% -<br />5% human albumin solutions. Monitor regularly the electrolyte status of the patient and<br />take appropriate steps to restore or maintain the electrolyte balance when albumin is<br />administered.<br />4.4.5 Coagulation Abnormalities<br />Regular monitoring of coagulation and hematology parameters is necessary if<br />comparatively large volumes are to be replaced. Care must be taken to ensure adequate<br />substitution of other blood constituents (coagulation factors, electrolytes, platelets and<br />erythrocytes).<br />4.4.6 Laboratory Monitoring<br />Monitor regularly hemodynamic parameters during administration of Albutein&reg; 20%; this<br />may include:<br />&bull; Arterial blood pressure and pulse rate<br />&bull; Central venous pressure<br />&bull; Pulmonary artery occlusion pressure<br />&bull; Urine output<br />&bull; Electrolytes</p><p>&bull; Hematocrit/hemoglobin<br />4.4.7 Application Precautions<br />Albutein&reg; 20% must not be diluted with sterile water for injection as this may cause<br />hemolysis in recipients. The product can be diluted in an isotonic solution (e.g., 5%<br />dextrose in water or 0.9% sodium chloride) [see Posology and Method of Administration</p><p>4.4.8 Transmissible Infectious Agents<br />Albumin is a derivative of human blood. Based on effective donor screening and product<br />manufacturing processes, it carries an extremely remote risk for transmission of viral<br />diseases. A theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD) is also<br />considered extremely remote. No cases of transmission of viral diseases or CJD have been<br />identified for Albutein&reg; 20%.<br />Solutions of Albutein&reg; 20% should not be used if they appear turbid or if there is sediment<br />in the bottle. Do not begin administration more than 4 hours after the container has been<br />entered. Discard unused portion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No specific interactions of human albumin with other medicinal products are known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category C: Animal reproduction studies have not been conducted with<br />Albutein&reg; 20%. It is also not known whether Albutein&reg; 20% can cause fetal harm when<br />administered to a pregnant woman or can affect reproductive capacity. Albutein&reg; 20%<br />should be given to a pregnant woman only if clearly needed.<br />Nursing Mothers: There is no human or animal data on the use of Albutein&reg; 20% for<br />lactating women. Use only if clearly needed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Albutein&reg; 20% has not been reported to affect the ability to drive or operate machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>a. Summary of the safety profile</p><p>The most serious adverse reactions are anaphylactic shock, heart failure and<br />pulmonary edema.<br />The most common adverse reactions are anaphylactoid type reactions.<br />The most common adverse reactions include fever and chills, rash, nausea,<br />vomiting, tachycardia and hypotension. Adverse reactions to Albutein&reg; 20%<br />normally resolve when the infusion rate is slowed or the infusion is stopped.<br />Should an adverse reaction occur, slow or stop the infusion for a short period of<br />time which may result in the disappearance of the symptoms. In case of severe<br />reactions, the infusion is stopped and appropriate treatment initiated.<br />Albutein&reg; 20%, particularly if administered rapidly, may result in vascular<br />overload with resultant pulmonary edema.<br />b. Tabulated summary of adverse reactions<br />Because adverse reactions are reported voluntarily post-approval from a<br />population of uncertain size, it is not always possible to reliably estimate their<br />frequency or to establish a causal relationship to product exposure. The following<br />adverse reactions have been identified during post approval use of Albutein&reg; 20%,<br />in decreasing order of significance:<br />&bull; Anaphylactic shock<br />&bull; Heart failure<br />&bull; Pulmonary edema<br />&bull; Hypotension<br />&bull; Tachycardia<br />&bull; Vomiting<br />&bull; Urticaria<br />&bull; Rash<br />&bull; Headache<br />&bull; Chills<br />&bull; Fever<br />&bull; Flushing<br />&bull; Nausea<br />c. Description of selected adverse reactions<br />The most serious adverse reactions are anaphylactic shock, heart failure and<br />pulmonary edema.<br />The most common adverse reactions are anaphylactoid type reactions.</p><p>Adverse reactions to Albutein&reg; 20% normally resolve when the infusion rate is<br />slowed or the infusion is stopped.<br />In the case of severe reactions, the infusion is stopped and appropriate treatment<br />initiated.<br />d. Pediatric population<br />No human or animal data. Use only if clearly needed.<br />e. Other special population(s)<br />No human or animal data. Use only if clearly needed.<br />To report SUSPECTED REACTIONS, contact Grifols at +1-323-225-2221.<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-<br />2334-2340.<br />&bull; Toll free phone: 8002490000<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypervolemia may occur if the dosage and rate of infusion are too high. At the first<br />clinical signs of cardiovascular overload (headache, dyspnea, jugular vein congestion),<br />or increased blood pressure, raised central venous pressure and pulmonary edema, the<br />infusion should be stopped immediately and the patient&rsquo;s hemodynamic parameters<br />carefully monitored.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Blood substitutes and plasma protein fractions,<br />Anatomical Therapeutic Chemical (ATC) code: B05AA01.<br />Human albumin accounts quantitatively for more than half of the total protein in the<br />plasma and represents about 10% of the protein synthesis activity of the liver. Physicochemical data: human albumin 4 to 5% is mildly hypooncotic to normal plasma.<br />Albutein&reg; 20% has a corresponding hyperoncotic effect.<br />The most important physiological functions of albumin result from its contribution to<br />oncotic pressure of the blood and transport function. Albumin stabilizes circulation<br />blood volume and is a carrier of hormones, enzymes, medicinal products and toxins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Under normal conditions, the total exchangeable albumin pool is 4 - 5 g/kg body<br />weight, of which 40 - 45% is present intravascularly and 55 - 60% in the extravascular<br />space. Increased capillary permeability will alter albumin kinetics and abnormal<br />distribution may occur in conditions such as severe burns or septic shock.<br />Under normal conditions, the average half-life of albumin is about 19 days. The balance<br />between synthesis and breakdown is normally achieved by feed-back regulation.<br />Elimination is predominantly intracellular and due to lysosome proteases.<br />In healthy subjects, less than 10% of infused albumin leaves the intravascular<br />compartment during the first 2 hours following infusion. There is considerable<br />individual variation in the effect on plasma volume.<br />In some patients the plasma volume can remain increased for some hours. However, in<br />critically ill patients, albumin can leak out of the vascular space in substantial amounts<br />at an unpredictable rate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Human albumin is a normal constituent of human plasma and acts like physiological<br />albumin.<br />In animals, single dose toxicity testing is of little relevance and does not permit the<br />evaluation of toxic or lethal doses or of a dose-effect relationship.<br />Repeated dose toxicity testing is impracticable due to the development of antibodies to<br />heterologous protein in animal models.<br />To date, Albutein&reg; 20% has not been reported to be associated with embryo-fetal<br />toxicity, oncogenic or mutagenic potential.<br />No signs of acute toxicity have been described in animal models.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:217px">Name of Ingredients</td><td style="width:22px">Quantity</td><td style="width:51px">Units</td><td style="width:79px">Function</td><td style="width:169px">Reference</td></tr><tr><td style="width:217px">Sodium Chloride (q.s. sodium ion)<br />Sodium Caprylate<br />Sodium N-Acetyltryptophanate<br />Water for Injection q.s.</td><td style="width:22px">0.145<br />0.016<br />0.016<br />1</td><td style="width:51px">mmoL<br />mmoL<br />mmoL<br />mL</td><td style="width:79px">Isotonic Agent<br />Stabilizer<br />Stabilizer<br />Solvent</td><td style="width:169px">U.S.P./Ph. Eur.<br />Ph. Eur.<br />Ph. Eur.<br />U.S.P./Ph. Eur.</td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Albutein&reg; 20% must not be mixed with other medicinal products (except the<br />recommended diluents), whole blood and packed red cells.<br />Do not administer protein hydrolysates or alcohol via the same administration set used<br />for Albutein&reg; 20%. It may cause the proteins to precipitate.<br />Albutein&reg; 20% must not be diluted with sterile water for injection as this may cause<br />hemolysis in recipients. The product can be diluted in an isotonic solution (e.g., 5%<br />Dextrose in Water or 0.9% sodium chloride).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Albutein® 20% is stable for three years provided that storage temperature does not
exceed 30 C.
Do not begin administration more than 4 hours after the container has been entered.
Discard unused portion.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store Albutein&reg; 20% at temperatures not exceeding 30 C.<br />Protect from freezing</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Albutein&reg; 20% is supplied in: 50 mL, clear, Type II glass vial containing 10 g of albumin</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Directions for Use:<br />When an Administration Set is Used<br />Flip off plastic cap on top of the vial and expose rubber stopper. Cleanse exposed rubber<br />stopper with suitable germicidal solution, being sure to remove any excess. Observe<br />aseptic technique and prepare sterile intravenous equipment as follows:<br />1. Close clamp on administration set.<br />2. With bottle upright, squeeze drip chamber, thrust piercing pin straight through<br />stopper center. Do not twist or angle.<br />3. Immediately invert bottle, release drip chamber to automatically establish proper<br />fluid level in drip chamber (half full).<br />4. Attach infusion set to administration set, open clamp and allow solution to expel air<br />from tubing and needle, then close clamp.<br />5. Make venipuncture and adjust flow.<br />6. Discard all administration equipment after use. Discard any unused contents.<br />When an Administration Set is Not Used<br />Flip off plastic cap on top of the vial and expose rubber stopper. Cleanse exposed rubber<br />stopper with suitable germicidal solution, being sure to remove any excess. Observe<br />aseptic technique and prepare sterile intravenous equipment as follows:<br />1. Using aseptic technique, attach filter needle to a sterile disposable plastic syringe.<br />2. Insert filter needle into Albutein&reg; 20%.<br />3. Aspirate Albutein&reg;20% from the vial into the syringe.<br />4. Remove and discard the filter needle from the syringe.<br />5. Attach desired size needle to syringe.<br />6. Discard all administration equipment after use. Discard any unused contents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Grifols Biologicals Inc.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                February 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>